HALO Sale Disclosure
Torley Helen · SEC Form 4 · Filed Aug 19, 2026
Sale
Calculated transaction value
$765.78K
Torley Helen President And CEO
HALO
Transaction date
Aug 19, 2026
Public filing date
Aug 20, 2026
Filing lag
Filed 1 day later
HALO daily price context
Close on/before transaction
$107.62
Aug 19, 2026
Close before public filing
$107.62
Aug 19, 2026
Return since public filing
+1.67%
Through Sep 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,200 shares @ $106.36
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001159036-26-000108
Filing cohort
Transactions in this filing
Showing 15 of 17
Trades
17
Issuers
1
Estimated value
$8.48M
Buys / sales
0 / 11
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Halozyme Therapeutics, Inc. HALO | Exercise | Aug 19, 2026 | $368.2K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Aug 19, 2026 | $368.2K |
| Halozyme Therapeutics, Inc. HALO Current | Sale | Aug 19, 2026 | $765.78K |
| Halozyme Therapeutics, Inc. HALO | Sale | Aug 19, 2026 | $1.03M |
| Halozyme Therapeutics, Inc. HALO | Sale | Aug 19, 2026 | $344.85K |
| Halozyme Therapeutics, Inc. HALO | Sale | Aug 18, 2026 | $587.88K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Aug 18, 2026 | $368.2K |
| Halozyme Therapeutics, Inc. HALO | Sale | Aug 18, 2026 | $985.82K |
| Halozyme Therapeutics, Inc. HALO | Sale | Aug 18, 2026 | $509.83K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Aug 18, 2026 | $368.2K |
| Halozyme Therapeutics, Inc. HALO | Sale | Aug 17, 2026 | $922.98K |
| Halozyme Therapeutics, Inc. HALO | Sale | Aug 17, 2026 | $213.71K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Aug 17, 2026 | $368.2K |
| Halozyme Therapeutics, Inc. HALO | Sale | Aug 17, 2026 | $50.23K |
| Halozyme Therapeutics, Inc. HALO | Sale | Aug 17, 2026 | $776.12K |